These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 9989235)
1. Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis. Rawlings ND; Barrett AJ Biochim Biophys Acta; 1999 Jan; 1429(2):496-500. PubMed ID: 9989235 [TBL] [Abstract][Full Text] [Related]
2. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis. Ezaki J; Takeda-Ezaki M; Oda K; Kominami E Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303 [TBL] [Abstract][Full Text] [Related]
3. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes. Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752 [TBL] [Abstract][Full Text] [Related]
4. Two novel CLN2 gene mutations in a Chinese patient with classical late-infantile neuronal ceroid lipofuscinosis. Lam CW; Poon PM; Tong SF; Ko CH Am J Med Genet; 2001 Mar; 99(2):161-3. PubMed ID: 11241479 [No Abstract] [Full Text] [Related]
5. The substrate range of tripeptidyl-peptidase I. Bernardini F; Warburton MJ Eur J Paediatr Neurol; 2001; 5 Suppl A():69-72. PubMed ID: 11589011 [TBL] [Abstract][Full Text] [Related]
6. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis. Bernardini F; Warburton MJ Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963 [TBL] [Abstract][Full Text] [Related]
7. Pre- and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities. Young EP; Worthington VC; Jackson M; Winchester BG Eur J Paediatr Neurol; 2001; 5 Suppl A():193-6. PubMed ID: 11588996 [TBL] [Abstract][Full Text] [Related]
8. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316 [TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models. Sohar I; Sleat DE; Jadot M; Lobel P J Neurochem; 1999 Aug; 73(2):700-11. PubMed ID: 10428067 [TBL] [Abstract][Full Text] [Related]
10. A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. Sleat DE; Wiseman JA; El-Banna M; Kim KH; Mao Q; Price S; Macauley SL; Sidman RL; Shen MM; Zhao Q; Passini MA; Davidson BL; Stewart GR; Lobel P J Neurosci; 2004 Oct; 24(41):9117-26. PubMed ID: 15483130 [TBL] [Abstract][Full Text] [Related]
11. Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase. Ezaki J; Takeda-Ezaki M; Kominami E J Biochem; 2000 Sep; 128(3):509-16. PubMed ID: 10965052 [TBL] [Abstract][Full Text] [Related]
12. Exclusion of late infantile neuronal ceroid lipofuscinosis (LINCL) in a fetus by assay of tripeptidyl peptidase I in chorionic villi. Young EP; Winchester BG; Peter Logan W; Wheeler RB; Lake BD Prenat Diagn; 2000 Apr; 20(4):337-9. PubMed ID: 10740208 [TBL] [Abstract][Full Text] [Related]
13. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I. Vines DJ; Warburton MJ FEBS Lett; 1999 Jan; 443(2):131-5. PubMed ID: 9989590 [TBL] [Abstract][Full Text] [Related]
14. Specific substrate for CLN2 protease/tripeptidyl-peptidase I assay. Junaid MA; Brooks SS; Pullarkat RK Eur J Paediatr Neurol; 2001; 5 Suppl A():63-8. PubMed ID: 11589010 [TBL] [Abstract][Full Text] [Related]
15. Characterization and chromosomal mapping of a mouse ortholog of the late-infantile ceroid-lipofuscinosis gene CLN2. Katz ML; Liu PC; Grob-Nunn SE; Shibuya H; Johnson GS Mamm Genome; 1999 Nov; 10(11):1050-3. PubMed ID: 10556422 [TBL] [Abstract][Full Text] [Related]
16. Rapid detection of the two most common CLN2 mutations causing classical late infantile neuronal ceroid lipofuscinosis. Bodzioch M; Aslanidis C; Kacinski M; Zhong N; Wisniewski KE; Schmitz G Clin Chem; 2000 Oct; 46(10):1696-9. PubMed ID: 11017954 [No Abstract] [Full Text] [Related]
17. Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders. Wisniewski KE; Kida E; Walus M; Wujek P; Kaczmarski W; Golabek AA Eur J Paediatr Neurol; 2001; 5 Suppl A():73-9. PubMed ID: 11589013 [TBL] [Abstract][Full Text] [Related]
18. An Australasian diagnostic service for the neuronal ceroid lipofuscinoses. Muller VJ; Paton BC; Fietz MJ Eur J Paediatr Neurol; 2001; 5 Suppl A():197-201. PubMed ID: 11588997 [TBL] [Abstract][Full Text] [Related]
19. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis. Yu F; Liu XM; Chen YH; Zhang SQ; Wang K Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578 [No Abstract] [Full Text] [Related]
20. Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis. Liu CG; Sleat DE; Donnelly RJ; Lobel P Genomics; 1998 Jun; 50(2):206-12. PubMed ID: 9653647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]